Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Topped the Market on Thursday

By Eric Volkman – Sep 30, 2021 at 6:10PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Customers expressed a high degree of satisfaction with the company in an influential survey.

What happened

Bucking the downbeat trend of the broader stock market on Thursday, Teladoc Health (TDOC 0.69%) shares eked out a slight gain on the day. The catalyst seems to have been the news of good performance in a study conducted by a noted consumer-market researcher.

So what

Teladoc announced that it has ranked No. 1 among direct-to-consumer (DTC) companies in the very specific J.D. Power 2021 U.S. Telehealth Satisfaction Study. The company's overall satisfaction score was 874, which is almost 30 points above the average for that particular category.

Teladoc added that it also took first place in all of the study's sub-categories. These include customer service and consultation.

Elderly person using telehealth services.

Image source: Getty Images.

This is not a first for Teladoc: The healthcare company didn't hesitate to point out that it has taken No. 1 in two of the three annual studies published by the researcher so far.

J.D. Power is a well-recognized name in the field of consumer analytics. It's perhaps best known for its rankings of automobiles, although it researches a wide variety of other products and industries. 

In the Telehealth Satisfaction Study, the researcher pointed out that 36% of the healthcare consumers it tracks for its research have utilized telehealth products in 2021. That's four times higher than the rate at the same time last year.

Now what

Teladoc's performance is notable, given that in the telehealth industry generally, "customer satisfaction has declined during the same period, with many users citing limited access to the services they need and inconsistencies in the care they receive," J.D. Power's managing director of global healthcare intelligence James Breem was quoted as saying.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$29.20 (0.69%) $0.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.